KRT9

Chr 17AD

keratin 9

Also known as: CK-9, EPPK, K9

This gene encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this gene cause epidermolytic palmoplantar keratoderma. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Palmoplantar keratoderma, epidermolytic, 1MIM #144200
AD
0
Active trials
24
Pathogenic / LP
233
ClinVar variants
5
Pubs (1 yr)
0.2
Missense Z
0.92
LOEUF
Clinical SummaryKRT9
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
24 Pathogenic / Likely Pathogenic· 131 VUS of 233 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.92LOEUF
pLI 0.000
Z-score 1.84
OE 0.58 (0.380.92)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.20Z-score
OE missense 0.97 (0.891.06)
338 obs / 348.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.58 (0.380.92)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.97 (0.891.06)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.03
01.21.6
LoF obs/exp: 13 / 22.4Missense obs/exp: 338 / 348.4Syn Z: -0.29

ClinVar Variant Classifications

233 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic7
VUS131
Likely Benign35
Benign24
Conflicting19
17
Pathogenic
7
Likely Pathogenic
131
VUS
35
Likely Benign
24
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
10
7
0
17
Likely Pathogenic
0
7
0
0
7
VUS
1
104
22
4
131
Likely Benign
0
7
6
22
35
Benign
0
1
17
6
24
Conflicting
19
Total11295232233

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KRT9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

KRT9-related palmoplantar keratoderma Vorner-Unna-Thost (epidermolytic)

definitive
ADDominant NegativeAltered Gene Product Structure
Skin
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

KERATIN 9, TYPE I; KRT9
MIM #607606 · *

Palmoplantar keratoderma, epidermolytic, 1

MIM #144200

Molecular basis of disorder known

Autosomal dominant

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Salivary annexin A1: A candidate biomarker for periodontitis.
Casarin RCV et al.·J Clin Periodontol
2023
Hereditary palmoplantar keratoderma - phenotypes and mutations in 64 patients.
Harjama L et al.·J Eur Acad Dermatol Venereol
2021Cohort
Top 10 resultsSearch PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC